Metindol

Indometacin, the active ingredient in Metindol, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is prescribed to reduce pain, swelling and stiffness in inflammatory joint disorders and acute painful conditions. GNH USA supplies Metindol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin is used to manage inflammatory and painful conditions affecting the musculoskeletal system. - Rheumatoid arthritis: decreases joint inflammation and pain, improving function. - Osteoarthritis: relieves chronic joint pain and stiffness. - Ankylosing spondylitis: reduces spinal inflammation and discomfort. - Gouty arthritis: alleviates acute gout attacks and associated swelling. - Acute pain and inflammation: provides rapid relief of short‑term inflammatory pain.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Renal impairment or sudden loss of kidney function. - Severe hypersensitivity reactions, including Stevens‑Johnson syndrome. - Hepatotoxicity with jaundice. - Cardiovascular events such as myocardial infarction or stroke.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Renal function: assess baseline creatinine and monitor during treatment. - Hepatic health: evaluate liver enzymes before and during use. - Gastrointestinal risk: avoid in patients with active ulcers or a history of severe GI bleeding. - Cardiovascular disease: use cautiously in patients with known heart disease or hypertension. - Concomitant NSAIDs or anticoagulants: increase bleeding risk; evaluate necessity. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Indometacin can alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Lithium: increased lithium levels and toxicity. - Methotrexate: reduced renal clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: risk of electrolyte imbalance and renal impairment. - Other NSAIDs or corticosteroids: additive gastrointestinal toxicity.